SNOA
SNOA
NASDAQ · Pharmaceuticals

Sonoma Pharmaceuticals Inc

$2.36
+0.02 (+0.85%)
As of Mar 25, 5:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +447.9% upside
Low Target $7.21
Average Target $12.93
High Target $14.12
Current Price $2.36
Current
$2.36
Target
$12.93
$7.21 $12.93 avg $14.12
Scenario Analysis
Bear Case
$7.21
205.5%
Low target
Base Case
$12.93
+447.9%
Avg target
Bull Case
$14.12
+498.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$6.92
-65.9% from high
52-Week Low
$1.75
+34.9% from low
Target vs 52W High
$12.93
+86.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%